QUANTUMONLINE.COM SECURITY DESCRIPTION:  Merrill Lynch & Co., Inc., Medium-Term Notes, Series B, 0.25% Callable and Exchangeable Stock Portfolio-Linked Notes, issue price $1,094.39 per note, due 4/27/2006, linked to the performance of the common stock of Pfizer Inc., Sepracor Inc. and Warner-Lambert Co. The notes pay distributions of 0.25% per annum semi-annually on 4/27 & 10/27. The notes are redeemable for cash at the issuer's option on or after 4/28/2002 and exchangeable for cash any time on or after 6/30/1999 at the holder's option. At maturity or when called by the issuer, the holder will receive the greater of $1000 or the sum of the products for each portfolio security of the applicable share multiplier times the average price of the common stocks immediately prior to the redemption or maturity date. If exchanged by the holder, the holder will receive the greater of $1000 or the sum of the products for each portfolio security of the applicable share multiplier times the price of the common stocks on the day following the receipt of the exchange notice. The initial share multiplier are 2.2352 for Pfizer, 2.8383 for Sepracor and 4.1433 for Warner-Lambert. See the IPO Prospectus for further information on the notes and the exchange and redemption provisions by clicking on the ‘Link to IPO Prospectus’ provided below.

Company's Online Information Links

HOME PAGE:     http://www.ml.com/ (This parent company URL is for reference only and does not have specific information on the security.)

Company's Online SEC EDGAR Filings

Company's SEC EDGAR Filings

Go to SEC Filings

Company's Email Address Links

Email Address	investor_relations@ml.com
Email Contact Form on Website	Go to Email Form

Address and Phone Numbers

Address:   4 World Financial Center, North Tower, New York, NY 10080
Main Phone Number	212-449-1000
Fax Number	212-236-4384
Investor Relations	866-607-1234
Toll Free Phone Number	800-637-7455

CEO - David H. Komansky

CFO - Thomas H. Patrick